Trial Profile
Efficacy and Safety of Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly Cirrhotic Patients: a Real Life Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2018
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 Oct 2016 Results (n=162) presented at the 24th United European Gastroenterology Week.
- 17 Apr 2016 Results presented at The International Liver Congress™ 2016.
- 14 Mar 2016 New trial record